Bank Of America Corp Black Diamond Therapeutics, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 18,887 shares of BDTX stock, worth $89,335. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,887
Previous 11,375
66.04%
Holding current value
$89,335
Previous $57,000
54.39%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BDTX
# of Institutions
100Shares Held
47.3MCall Options Held
108KPut Options Held
24.8K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.7MShares$50.4 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.52MShares$40.3 Million0.66% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$21 Million1.96% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$15.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.13MShares$10.1 Million0.0% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $172M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...